General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Study Summary

The purpose of the study is to investigate the safety and effectiveness of Awiqli in participants with diabetes mellitus under real world clinical practice in Japan. Participants will get Awiqli as prescribed by the study doctor. The study will last for about 1 year.

Conditions

Diabetes Mellitus, Type 1

Interventions / Drugs

Insulin Icodec

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment630 participants

Primary Completion—

Lead SponsorNovo Nordisk A/S

Data Retrieved2026-04-11 02:55:47.366724+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.